Studies in breast and lung cancer models have linked RCC1 overexpression to increased tumor invasiveness and resistance to apoptosis, indicating that RCC1 may be crucial for cancer cell survival under therapeutic stress [17,18]. This evidence concerns the gene RCC1 and lung cancer.